Martin Howard

2.0k total citations
33 papers, 1.2k citations indexed

About

Martin Howard is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Martin Howard has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Public Health, Environmental and Occupational Health and 7 papers in Genetics. Recurrent topics in Martin Howard's work include Palliative Care and End-of-Life Issues (9 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Cancer survivorship and care (6 papers). Martin Howard is often cited by papers focused on Palliative Care and End-of-Life Issues (9 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Cancer survivorship and care (6 papers). Martin Howard collaborates with scholars based in United Kingdom, United States and Australia. Martin Howard's co-authors include Eve Roman, Debra Howell, Russell Patmore, Anne C Garry, Stephen J. Proctor, Annette Neylon, P. W. G. Saunders, Penelope R. A. Taylor, Alexandra Smith and Dorothy McCaughan and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Martin Howard

31 papers receiving 1.1k citations

Peers

Countries citing papers authored by Martin Howard

Since Specialization

Citations

This map shows the geographic impact of Martin Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Howard more than expected).

Fields of papers citing papers by Martin Howard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Howard. The network helps show where Martin Howard may publish in the future.

Co-authorship network of co-authors of Martin Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Howard. A scholar is included among the top collaborators of Martin Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Howard. Martin Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rehabilitation to enable recovery from COVID-19: a rapid systematic review 2021 ·Physiotherapy ·Victoria A Goodwin, Louise Allan, Alison Bethel, Alison Cowley, Jane Cross, Jo Day, Avril Drummond, (unknown), Martin Howard, (unknown), Jo Thompson Coon, Sarah E Lamb	41
2	Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network 2020 ·BMJ Supportive & Palliative Care ·Rebecca Sheridan, Eve Roman, Alex Smith, A. Turner, Anne C Garry, Russell Patmore, Martin Howard, Debra Howell	24
3	The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor 2019 ·Journal of Medicinal Chemistry ·Frederick W. Goldberg, M. Raymond V. Finlay, Attilla Ting, David T. Beattie, Gillian M. Lamont, Charlene Fallan, Gail L. Wrigley, Marianne Schimpl, Martin Howard, Beth Williamson, Mercedes Vázquez–Chantada, Derek Barratt, Barry R. Davies, Elaine Cadogan, Antonio Ramos‐Montoya, Emma Dean	66
4	Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study 2019 ·European Journal of Oncology Nursing ·Dorothy McCaughan, Eve Roman, Alexandra Smith, Anne C Garry, Miriam J. Johnson, Russell Patmore, Martin Howard, Debra Howell	15
5	Palliative care specialists’ perceptions concerning referral of haematology patients to their services: findings from a qualitative study 2018 ·BMC Palliative Care ·Dorothy McCaughan, Eve Roman, Alexandra Smith, Anne C Garry, Miriam J. Johnson, Russell Patmore, Martin Howard, Debra Howell	50
6	Determinants of hospital death in haematological cancers: findings from a qualitative study 2017 ·BMJ Supportive & Palliative Care ·Dorothy McCaughan, Eve Roman, Alexandra Smith, Anne C Garry, Miriam J. Johnson, Russell Patmore, Martin Howard, Debra Howell	34
7	Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death 2013 ·BMC Palliative Care ·Debra Howell, Han‐I Wang, Alexandra Smith, Martin Howard, Russell Patmore, Eve Roman	34
8	Medicinal chemistry approaches to avoid aldehyde oxidase metabolism 2012 ·Bioorganic & Medicinal Chemistry Letters ·David C. Pryde, Thien-Duc Tran, Peter Jones, (unknown), Martin Howard, Iain Gardner, Ruth Hyland, Rob Webster, (unknown), Sharan K. Bagal, Kiyoyuki Omoto, Richard Schneider, Jian Lin	31
9	SNARE-dependent glutamate release in megakaryocytes 2010 ·Experimental Hematology ·Catherine Thompson, Tatjana Schilling, Martin Howard, Paul G. Genever	12
10	Excretion and Metabolism of Lersivirine (5-{[3,5-Diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a Next-Generation Non-Nucleoside Reverse Transcriptase Inhibitor, after Administration of [14C]Lersivirine to Healthy Volunteers 2010 ·Drug Metabolism and Disposition ·Manoli Vourvahis, (unknown), Angus N. R. Nedderman, Ruth Hyland, Iain Gardner, Martin Howard, Sarah Kempshall, Claire Collins, Robert R. LaBadie	21
11	The Metabolism and Toxicity of Furosemide in the Wistar Rat and CD-1 Mouse: a Chemical and Biochemical Definition of the Toxicophore 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Dominic P. Williams, Daniel J. Antoine, (unknown), Russell G. Jones, Laura E. Randle, Anthony G. Payne, Martin Howard, Iain Gardner, Julian Blagg, B. Kevin Park	50
12	Outreach monitoring service for patients with indolent B‐cell and plasma cell disorders: a UK experience 2007 ·British Journal of Haematology ·Andy C. Rawstron, Elena Jones, (unknown), (unknown), (unknown), Carol Reid, Surita Dalal, Martin Howard, Graeme Smith, Peter Hillmen, Roger G. Owen, Andrew Jack	12
13	Haemophagocytosis in acute myeloid leukaemia t(8;16) 2007 ·British Journal of Haematology ·Martin Howard, H. J. Dickinson	1
14	Skin lesions in plasmacytoid dendritic cell leukaemia 2007 ·British Journal of Haematology ·(unknown), Martin Howard	1
15	Immunoglobulin crystals in peripheral blood lymphocytes in chronic lymphocytic leukaemia 2003 ·British Journal of Haematology ·Martin Howard, M M Reid	0
16	Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patients 2003 ·British Journal of Haematology ·Annette Neylon, P. W. G. Saunders, Martin Howard, Stephen J. Proctor, Penelope R. A. Taylor, (unknown)	248
17	Is thrombophilia a factor in the development of hemiplegic cerebral palsy? 2001 ·Developmental Medicine & Child Neurology ·Robert A. Smith, (unknown), Martin Howard, Malcolm I. Levene	7
18	Is thrombophilia a factor in the development of hemiplegic cerebral palsy? 2001 ·Developmental Medicine & Child Neurology ·Robert A. Smith, (unknown), Martin Howard, Malcolm I. Levene	26
19	Book Review: To Improve the Evidence of Medicine: The 18th Century British Origins of a Critical Approach 2001 ·Journal of the Royal Society of Medicine ·Martin Howard	24
20	Alpha interferon gene deletions in post‐transplant lymphoma 1997 ·British Journal of Haematology ·(unknown), Brian Angus, (unknown), John H. Dark, (unknown), Sue Miller, Martin Howard, (unknown), (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact